For its third fiscal quarter (ending September 30), Utah Medical Products Inc (NASDAQ: UTMD) has reported a -20% decline in E.P.S. from $1.02 a year ago to $0.82 in the current quarter. E.P.S. were $3.54 for the latest four quarters through September 30 versus $4.28 for the same period a year ago — a decline of -17%.
Recent Price Action
Utah Medical Products Inc (NASDAQ: UTMD) stock closed at $60.45 on 10/23/25 after a slight decline of -0.9%. However, this decline was accompanied by unusually low trading volume at 64% of normal. The stock is unchanged during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Utah Medical Products has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Utah Medical Products has a slightly negative Appreciation Score of 36 and a slightly negative Power Rating of 36, leading to the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment